- Home
- Applications
- biomarkers
Refine by
Biomarkers Product Applications
29 applications found
Measuring mRNA transcript abundance with RNASeq methods offers clinical researchers a powerful platform to examine changes in the expression levels of multiple biomarkers. The power of targeted RNASeq lies in its ability to count the number of reads of a given transcript in a sample as a surrogate for expression level, much like a digital PCR system but able to measure 100s of biomarkers simultaneously. ...
ByAccuGenomics, Inc. based in Wilmington, NORTH CAROLINA (USA)
Aidar Research offers CROs a cutting-edge approach by making decentralized and hybrid trials achievable and increasingly accessible to collect unique digital biomarkers, and to measure drug effectiveness, dosage variances, adverse reactions, and distinctive changes at the individual level thereby driving better outcomes, enhancing user engagement and fostering ...
ByAidar Health based in Baltimore, MARYLAND (USA)
Combine high sensitivity biomarker testing with traditional blood gas and ...
ByProxim Diagnostics Corp. based in Santa Clara, CALIFORNIA (USA)
Discover autoantigens in autoimmune diseases, delineate new candidate biomarkers. Autoantibodies are present in the blood of all healthy individuals. However, when directed at high levels against protein targets in specific tissues, autoantibodies can be a major cause of autoimmune diseases. They are also important biomarkers for diagnosis of these conditions. ...
ByCambridge Protein Arrays Ltd. (CPAP) based in Cambridge, UNITED KINGDOM
Microbiotica is using best-in-class clinical data and sample sets coupled with its unrivalled microbiome profiling capability to progress best-in-class therapeutics and biomarkers. Microbiotica has programs in IBD, Immuno-oncology and Gut Epithelial Barrier Repair developing medicines and biomarkers based on microbiota. ...
ByMicrobiotica Limited based in Little Chesterford, UNITED KINGDOM
Our experience in metagenomic evaluation of large patient cohorts provides know-how and understanding regarding microbiome related conditions and can be applied for target evaluation, and for biomarker identification and development of subsequent patient stratification tools. ...
ByMetabogen AB based in Stockholm, SWEDEN
Robovision can provide or develop powerful tools to enhance the detection, classification, and quantification of lesions or ...
ByRobovision BV based in Ghent, BELGIUM
Non-small cell lung cancer (NSCLC) is not a single disease, but a collection of cancer types whose pathology is classified by histology (cells) and molecular profiling (genetic and protein ...
ByBiocept based in San Diego, CALIFORNIA (USA)
Kirkstall’s Quasi Vivo® system aims to establish and optimise a human in vitro 3D Blood Brain Barrier (BBB) in an effort to identify important mechanistic pathways for successful biomarker analysis, drug delivery and toxicity ...
ByKirkstall Ltd. based in York, UNITED KINGDOM
Providing physicians with innovative and meaningful assays for the earlier detection of clinically significantly prostate ...
ByMDxHealth based in Irvine, CALIFORNIA (USA)
Reading for DNA Digital Data Storage: Unprecedented amounts of data are being generated by new technologies - from Internet of Things sensors to ubiquitous digital devices - with the unintended consequence that data production will outpace our ability to store it efficiently. Next-generation digital data storage is critical. New solutions that are ultra-dense and ultra-durable are required. By converting binary data into synthetic DNA sequences, we could harness the power of DNA to store data efficiently and at ...
ByRoswell Biotechnologies Inc based in San Diego, CALIFORNIA (USA)
When it comes to brain health, you and your loved ones deserve as much clarity and accuracy as possible. That’s why Qynapse is dedicated to providing you and your physician with an objective view of your brain health. ...
ByQynapse based in Paris, FRANCE
In your environment - in your home - at the clinic. Current Testing is Failing the Modern World. Low-plex: Many types of tests are required to diagnose disease today. Centralized: Centralized testing is slow and complex and remains a barrier to connected health. Limited Access: Lack of access propagates disease in the community: Cost and testing are fundamental ...
ByRoswell Biotechnologies Inc based in San Diego, CALIFORNIA (USA)
Sepsis is one of the leading causes of death worldwide. It is a life-threatening condition caused by a dysregulated host response to infection, which can progress to multiple organ dysfunction, septic shock and even death 1. Every hour counts in sepsis. It’s a medical emergency that requires immediate diagnosis because any delay in treatment can dramatically reduce the chances of survival 2. ...
ByAbionic SA based in Epalinges, SWITZERLAND
Accelerate research with real-world data in cardiology across the industry. Join our forces to accelerate research in cardiology care, facilitate treatment improvement and optimize diagnosis and prediction of cardiovascular diseases. Together, we can provide healthcare professionals with decision support tools to improve healthcare outcomes for their ...
ByImplicity based in Paris, FRANCE
Colorectal cancer (CRC) is the third most common cancer all over the world. About 1.8 million new CRC cases were diagnosed globally in 2018, mostly in developed countries. The incidence of colorectal cancer is increasing in line with the ageing population. Early detection is key to successful treatment of the disease and related cost management. An efficient screening strategy is essential to detect the disease early, when it often does not produce symptoms. The currently available faecal occult blood test (FOBT) ...
ByDiagNodus Ltd. based in Cambridge, UNITED KINGDOM
Single cell RNA-Seq is revolutionizing the study of complex tissues and diseases. The powerful and easy-to-use tools in Partek® Flow® empower researchers to analyze their own single cell RNA-Seq ...
ByPartek Incorporated based in Chesterfield, MISSOURI (USA)
Gene expression is the most fundamental level at which the genotype gives rise to a phenotype. Whether you have RNA-Seq, qPCR or microarray data, Partek provides easy-to-use tools that guide you through the analysis process from start to finish within a point-and-click interface. With over 8,000 citations, see why our gene expression analysis tools are the most trusted in the genomics ...
ByPartek Incorporated based in Chesterfield, MISSOURI (USA)
You need a complete answer to provide the best ...
ByBiocept based in San Diego, CALIFORNIA (USA)
Tumor markers found in blood, urine and body tissues can be used in diagnosing and treating cancer. Each tumor marker is indicative of a particular disease and thus can be used for the screening, monitoring and diagnosis of specific tumor types. In addition to being used in prognosis, these molecular markers help to predict the response, resistance and toxicity to therapy. For example, BCR-ABL gene sequence detection is used to diagnose chronic myelogenous leukemia and acute lymphatic ...
ByAurora Biomed Inc. based in Vancouver, BRITISH COLUMBIA (CANADA)